U
WST icon

UBS’s West Pharmaceutical WST Stock Holding History

UBS’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$22K Buy
+500
New +$21.2K ﹤0.01% 7908
2014
Q2 		– Sell
-200
Closed -$9K – 10878
2014
Q1 		$9K Buy
+200
New +$9.41K ﹤0.01% 9041

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS's WST Position: Q3 2014 in Review

UBS increased its West Pharmaceutical (WST) stake by 4,925% in Q3 2014, buying an estimated $981K and bringing the position to 23,565 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3536.

UBS first reported a position in WST in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.09M in Q4 2013. 213 funds tracked by Wall St. Rank hold WST as of Q3 2014.

  • UBS held 23,565 shares of West Pharmaceutical worth $1.05M as of Q3 2014.
  • UBS bought 23,096 West Pharmaceutical shares in Q3 2014, an estimated $981K.
  • West Pharmaceutical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3536 holding.
  • UBS first reported a position in West Pharmaceutical in Q2 2013 and has held it in 6 quarters since.
  • UBS's West Pharmaceutical position peaked at $1.09M in Q4 2013.
  • 213 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.